Audrey Mercer is an Associate Professor in the Department of Pharmacology at UCL School of Pharmacy. Following a DEA (french predoctoral qualification) at the University of Montpellier, Dr Mercer undertook her PhD in the Department of Physiology at the Royal Free Hospital Medical School and the School of Pharmacy. Following a 2-year postdoctoral position, Dr Mercer was awarded an RCUK Academic Fellowship at the School and then a lectureship in 2012. Her research has been maintained through sustained grant funding from industry, the Biotechnology and Biological Sciences Research Council (BBSRC), the Medical Research Council (MRC), The Physiological Society, UCL Neuroscience Domain, Sigrid Rausing Trust, and the European Commission (EC) Horizon 2020. Dr. Mercer leads two research streams that aim to characterise the building blocks of cortical connections in both healthy and diseased (Parkinson’s disease) states. One stream focuses on studying cortical connections and neuronal characterisation (mainly in the CA2 region of the hippocampus) and providing both experimental data (new and archived) and essential scientific expertise on hippocampal circuitry to a large collaborative project, the Human Brain Project funded by the European Commission. Her second research stream relates to the study of cortical circuitry in a pre-motor model of Parkinson’s disease and the search for new therapeutic avenues for this disease including GLP-1 receptor agonists, probiotics and gene therapy.
Audrey Mercer is an Associate Professor in the Department of Pharmacology at UCL School of Pharmacy. Following a DEA (french predoctoral qualification) at the University of Montpellier, Dr Mercer undertook her PhD in the Department of Physiology at the Royal Free Hospital Medical School and the School of Pharmacy. Following a 2-year postdoctoral position, Dr Mercer was awarded an RCUK Academic Fellowship at the School and then a lectureship in 2012. Her research has been maintained through sustained grant funding from industry, the Biotechnology and Biological Sciences Research Council (BBSRC), the Medical Research Council (MRC), The Physiological Society, UCL Neuroscience Domain, Sigrid Rausing Trust, and the European Commission (EC) Horizon 2020. Dr. Mercer leads two research streams that aim to characterise the building blocks of cortical connections in both healthy and diseased (Parkinson’s disease) states. One stream focuses on studying cortical connections and neuronal characterisation (mainly in the CA2 region of the hippocampus) and providing both experimental data (new and archived) and essential scientific expertise on hippocampal circuitry to a large collaborative project, the Human Brain Project funded by the European Commission. Her second research stream relates to the study of cortical circuitry in a pre-motor model of Parkinson’s disease and the search for new therapeutic avenues for this disease including GLP-1 receptor agonists, probiotics and gene therapy.